Zobrazeno 1 - 10
of 7 143
pro vyhledávání: ''
Autor:
Chiara Finocchiaro, Simona Toscano, Salvatore Lo Fermo, Francesco Patti, Enrico Millefiorini, Eleonora Sgarlata, Clara Grazia Chisari
Publikováno v:
Current Neuropharmacology. 20:1978-1987
Background: Progressive Multifocal Leukoencephalopathy (PML) is an opportunistic infection caused by John Cunningham virus (JCV) reactivation, potentially associated with natalizumab (NTZ) treatment for Multiple Sclerosis (MS). The anti-JCV antibodie
Publikováno v:
Current Drug Safety. 16:259-263
Background: Colistin utilization has gradually increased worldwide with the rising of multidrug-resistant (MDR) gram-negative bacilli despite its nephrotoxicity. Lipid emulsion (LE) is widely used for the toxic overdose treatment of various drugs. Ob
Autor:
Jun Li, Hong Zhou, Yan Yao, Junfa Yang, Ying Hu, Shuang Hu, Tao Xu, Shu-xian Wang, Jing-Li Min, Chen-chen Yang, Ze-Yuan Wei, Yin-Cui Wu, Liang-yun Li
Publikováno v:
Acta Pharmacol Sin
Acetaminophen (APAP) is one of the major causes of drug-induced acute liver injury, and ethanol may aggravate APAP-induced liver injury. The problem of ethanol- and APAP-induced liver injury becomes increasingly prominent, but the mechanism of ethano
Autor:
Ali Unlu, Gulsum Abusoglu, Fatma Humeyra Yerlikaya, Dilek Tezcan, Duygu Eryavuz Onmaz, Sema Yilmaz, Mustafa Onmaz, Sedat Abusoglu
Publikováno v:
Inflammopharmacology
Hydroxychloroquine has attracted attention in the treatment of COVID-19. Many conflicting findings have been reported regarding the efficacy and safety of this drug, which has been used safely in the rheumatological diseases for years. However, these
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding
Autor:
Andrea Giacometti, Gabriella d'Ettorre, Amedeo Capetti, William Gennari, Stefano Rusconi, Gaetana Sterrantino, Andrea Giacomelli, Vanni Borghi, Gianmaria Baldin, Alessandra Latini, Andrea De Vito, Cristina Mussini, Arturo Ciccullo, Simona Di Giambenedetto, Giordano Madeddu, Maria Vittoria Cossu
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 88:234-237
BACKGROUND Results from clinical trials and observational studies suggest that dolutegravir plus lamivudine could be an effective and well-tolerated option for simplification in HIV-1-positive patients. We aimed to assess long-time efficacy and safet
Autor:
Ikhlas Sindi, Mohamed El Yamani, May Ahmed Galal, Sherifa Kamal, Mohammed Fouad Shalaby, Hekma A. Abd El Latif, Raneem Masaood
Publikováno v:
BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-9 (2021)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background Dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia. An affiliation was found between the initiation of myocardial injury ailment and
Autor:
Cristina Matteo, Giovanni Schininà, Nunziatina Laura Parrinello, Roberta Sciortino, Salvatore Leotta, Giuseppe Milone, Gianna Maria Piccolo, Massimo Zucchetti, Francesco Di Raimondo, Maria Grazia Camuglia, Annalisa Condorelli, Maria Proietto
Publikováno v:
Cancer Chemotherapy and Pharmacology. 89:267-270
Relapse at the central nervous system (CNS) in acute myeloid leukemia (AML) carries a dismal prognosis. Treatment options are limited to intrathecal therapy, high-dose cytarabine, high-dose methotrexate, and radiotherapy. Novel strategies are needed.
Autor:
Takahiko Nagamine, Masaru Nakamura
Publikováno v:
Clinical Neuropharmacology. 44:205-209
Objective Clozapine is the second-generation antipsychotic that induces the largest metabolic disorders. However, evidence is limited to the liabilities based on sex differences. This study aimed to investigate the effects of clozapine treatment on m
Autor:
Aurélien Emmanuel Martinez, Martin Siegemund, Emmanuelle Landmann, Catia Marzolini, Anne Leuppi-Taegtmeyer, Michael Dickenmann, Manuel Battegay, Nadine Cueni, Alexa Hollinger
Publikováno v:
AIDS Research and Therapy, Vol 18, Iss 1, Pp 1-5 (2021)
AIDS Research and Therapy
AIDS Research and Therapy
Background We report a case of sudden, lethal metabolic acidosis in a 70-year-old man on long-term nucleoside reverse transcriptase inhibitor (NRTI) -based antiretroviral therapy (ART) who had developed atypical necrotizing fasciitis 1 month after ki
Publikováno v:
J Acquir Immune Defic Syndr
Journal of acquired immune deficiency syndromes (1999), vol 88, iss 1
Journal of acquired immune deficiency syndromes (1999), vol 88, iss 1
BACKGROUND Tenofovir alafenamide (TAF) is increasingly used in HIV treatment, with or without agents that require pharmacologic boosters such as ritonavir/cobicistat. Boosters increase TAF levels, so the TAF dose is lowered in single-pill combination